The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
Ryul Kim, Seokyung Hahn, Junghoon Shin, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Cancer Res Treat. 2016;48(3):907-916.   Published online 2015 Nov 17     DOI: https://doi.org/10.4143/crt.2015.359
Citations to this article as recorded by Crossref logo
SEOM clinical guidelines for the treatment of head and neck cancer (2020)
R. Mesia, L. Iglesias, J. Lambea, J. Martínez-Trufero, A. Soria, M. Taberna, J. Trigo, M. Chaves, A. García-Castaño, J. Cruz
Clinical and Translational Oncology.2021; 23(5): 913.     CrossRef
EHF suppresses cancer progression by inhibiting ETS1-mediated ZEB expression
Kaname Sakamoto, Kaori Endo, Kei Sakamoto, Kou Kayamori, Shogo Ehata, Jiro Ichikawa, Takashi Ando, Ryosuke Nakamura, Yujiro Kimura, Kunio Yoshizawa, Keisuke Masuyama, Tomoyuki Kawataki, Kunio Miyake, Hiroki Ishii, Tomonori Kawasaki, Keiji Miyazawa, Masao
Oncogenesis.2021;[Epub]     CrossRef
Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study
J. Martínez-Trufero, A. Lozano Borbalas, I. Pajares Bernad, M. Taberna Sanz, E. Ortega Izquierdo, B. Cirauqui Cirauqui, J. Rubió-Casadevall, M. Plana Serrahima, J.M. Ponce Ortega, I. Planas Toledano, J. Caballero, J. Marruecos Querol, L. Iglesias Docampo,
Clinical and Translational Oncology.2021; 23(8): 1666.     CrossRef
Divergent Roles of Induction Chemotherapy in Patients with Unresectable Locally Advanced Head and Neck Squamous Cell Carcinoma: A Population-Based Matched Cohort Study
Meng-Che Hsieh, Tzer-Zen Hwang, Chih-Chun Wang, Chuan-Chien Yang, Ching-Feng Lien, Chien-Chung Wang, Yu-Chen Shih, Wei-Ching Liu, Kun-Ming Rau
SSRN Electronic Journal .2021;[Epub]     CrossRef
Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma
Minsu Kwon, Gi-Hoon Nam, Hanul Jung, Seong A Kim, Seohyun Kim, Yeonju Choi, Yoon Se Lee, Hyo Jung Cho, In-San Kim
Cancer Letters.2021; 522: 198.     CrossRef
Indian clinical practice consensus guidelines for the management of oropharyngeal cancer
Kumar Prabhash, Govind Babu, Pankaj Chaturvedi, Moni Kuriakose, Praveen Birur, AnilK Anand, Ashish Kaushal, Abhishek Mahajan, Judita Syiemlieh, Manish Singhal, Munish Gairola, Prakash Ramachandra, Sumit Goyal, Subashini John, Rohit Nayyar, VijayM Patil, V
Indian Journal of Cancer.2020; 57(5): 12.     CrossRef
Locally advanced oral tongue cancer: Is organ preservation a safe option in resource-limited high-volume setting?
Muntazir Hussain, Muhammad Faisal, Muhammad Abu Bakar, Tahir Muhammad, Saman Qadeer, Sameen Mohtasham, Raza Hussain, Arif Jamshed
Annals of Maxillofacial Surgery.2020; 10(1): 158.     CrossRef
Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma
Armando De Virgilio, Andrea Costantino, Giuseppe Mercante, Gerardo Petruzzi, Daniela Sebastiani, Ciro Franzese, Marta Scorsetti, Raul Pellini, Luca Malvezzi, Giuseppe Spriano
Current Oncology Reports.2020;[Epub]     CrossRef
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)
Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Jung Hye Kwon, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun
BMC Cancer.2020;[Epub]     CrossRef
Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab
Andrea Ladányi, Bence Kapuvári, Eszter Papp, Erika Tóth, József Lövey, Katalin Horváth, Mária Gődény, Éva Remenár
Head & Neck.2019; 41(5): 1237.     CrossRef
Das Ende der TPF-Induktion bei lokoregionär fortgeschrittenen HNO-Karzinomen? Induktionschemotherapie gefolgt von Cetuximab und Bestrahlung nicht effektiver als simultane Radiochemotherapie
R. M. Hermann, H. Christiansen
Strahlentherapie und Onkologie.2019; 195(3): 281.     CrossRef
A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study)
Sadamoto Zenda, Yosuke Ota, Naomi Kiyota, Susumu Okano, Masato Fujii, Morimasa Kitamura, Shunji Takahashi, Tsutomu Ueda, Nobuya Monden, Takeharu Yamanaka, Makoto Tahara
Frontiers in Oncology.2019;[Epub]     CrossRef
Induction chemotherapy in head and neck cancers: Results and controversies
Max Gau, Andy Karabajakian, Thibaut Reverdy, Eve-Marie Neidhardt, Jérôme Fayette
Oral Oncology.2019; 95: 164.     CrossRef
CTX-Induktion gefolgt von Cetuximab und Bestrahlung nicht effektiver als simultane RCT
Hans Christiansen, Robert M. Hermann
InFo Hämatologie + Onkologie.2019; 22(7-8): 27.     CrossRef
A Phase II Study of Genexol‐PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Bhumsuk Keam, Keun‐Wook Lee, Se‐Hoon Lee, Jin‐Soo Kim, Jin Ho Kim, Hong‐Gyun Wu, Keun‐Yong Eom, Suzy Kim, Soon‐Hyun Ahn, Eun‐Jae Chung, Seong Keun Kwon, Woo‐Jin Jeong, Young Ho Jung, Ji‐Won Kim, Dae Seog Heo
The Oncologist.2019; 24(6): 751.     CrossRef
Platelet-lymphocyte and neutrophil-lymphocyte ratios
Yu-Hsi Liu, Yaoh-Shiang Lin
Journal of the Chinese Medical Association.2019; 82(11): 849.     CrossRef
Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter rando
Ying Lu, Dagui Chen, Jinhui Liang, Jianquan Gao, Zhanxiong Luo, Rensheng Wang, Wenqi Liu, Changjie Huang, Xuejian Ning, Meilian Liu, Haixin Huang
BMC Cancer.2019;[Epub]     CrossRef
SEOM clinical guidelines for the treatment of head and neck cancer (2017)
L. C. Iglesias Docampo, V. Arrazubi Arrula, N. Baste Rotllan, A. Carral Maseda, B. Cirauqui Cirauqui, Y. Escobar, J. J. Lambea Sorrosal, M. Pastor Borgoñón, A. Rueda, J. J. Cruz Hernández
Clinical and Translational Oncology.2018; 20(1): 75.     CrossRef
Radiotherapy for locally advanced resectable T3–T4 laryngeal cancer—does laryngeal preservation strategy compromise survival?
Hideya Yamazaki, Gen Suzuki, Satoaki Nakamura, Shigeru Hirano, Ken Yoshida, Koji Konishi, Teruki Teshima, Kazuhiko Ogawa
Journal of Radiation Research.2018; 59(1): 77.     CrossRef
Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?
Mickaël Burgy, Julie Leblanc, Christian Borel
Anti-Cancer Drugs.2018; 29(4): 287.     CrossRef
A retrospective study of treatment for curative synchronous double primary cancers of the head and neck and the esophagus
Tabito Okamoto, Chikatoshi Katada, Shouko Komori, Keishi Yamashita, Shunsuke Miyamoto, Koichi Kano, Yutomo Seino, Hiroshi Hosono, Hiroki Matsuba, Hiromitsu Moriya, Mitsuhiro Sugawara, Mizutomo Azuma, Hiromichi Ishiyama, Satoshi Tanabe, Kazushige Hayakawa,
Auris Nasus Larynx.2018; 45(5): 1053.     CrossRef
5-Fluorouracil induces inflammation and oxidative stress in the major salivary glands affecting salivary flow and saliva composition
Luana E. Bomfin, Cíntia M. Braga, Thais A. Oliveira, Conceição S. Martins, Danielle A. Foschetti, Ana A.Q.A. Santos, Deiziane V.S. Costa, Renata F.C. Leitão, Gerly A.C. Brito
Biochemical Pharmacology.2017;[Epub]     CrossRef
Clinical and Histologic Predictive Factors of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma
Georgia Karpathiou, Jean-Baptiste Giroult, Fabien Forest, Pierre Fournel, Alessandra Monaya, Marios Froudarakis, Jean Marc Dumollard, Jean Michel Prades, Marie Gavid, Michel Peoc'h
American Journal of Clinical Pathology.2016; 146(5): 546.     CrossRef